key point / upcoming breakthrough

Last Tuesday, Neuren through the work of Clive Blower, formally obtained the modification of the world patent of Trofinetide. request for modification of the Trofinetide production method with new system to very significantly increase the production quantity in a much shorter time. request made in June 2021, on the eve of the inauguration of Pilcher as sole administrator.in all likelihood, this is a fundamental step to understand in the first place, that already in June 2021 both had the knowledge that the phase 3 of Trofinetide would have a very positive course as it was. second, it certainly is a topic that Acadia and the FDA have compared to, to fine-tune the best advancement of the NDA.the fact that Neuren has been concerned in the last year to produce Trofinetide on a large scale is a clear signal that the matter is serious.the timing of the granting of this modification is in line with what the company has promised in terms of upcoming goals.I believe that this step is essential for a turning point.